Top Tweets for #CanNASH2021
Higher daily aramchol dose improves fibrosis in the ARMOR Study. In the first 20 F1-3 patients followed for 72 weeks, 60% showed fibrosis improvement by ≥1 stage; 26% showed #NASH resolution without worsening of fibrosis.@VladRatziu #livertwitter #TLMdX #LiverMtg21 #CanNASH2021

The concept that steatosis does not matter in NASH not holding true in the excellent presentation by Prof Arun Sanyal @AASLDtweets #LiverMtg21 #NAFLD #FattyLiver #NASH #CanNASH2021

Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian #NASH Network (#CanNASH)→https://t.co/KloOFPCXfX #LiverTwitter #NAFLD #FattyLiver #CLM21 #CanNASH2021 🇨🇦

Diabetes is the main risk factor for #NASH. My new review article on non-invasive diagnostic tools for #NAFLD is specific to type 2 #diabetes! A collaborative work with @Tulane and @UHN #CanNASH2021 @McGillGI @IDIGHProgram @CASLupdates DOI: 10.1016/j.jdiacomp.2021.107978

Honoured to be featured by the Canadian Liver Foundation for the "Meet the Researcher" series!! Showcasing both the scientific and human side of physicians and researchers engaged in liver research! #CanNASH2021 #NAFLD @CdnLiverFdtn @McGillGI
https://t.co/Q26hvs304i
My expert insight on current management of NASH is online on Clinical Care Options!! Please join me for an updated overview on lifestyle and pharmacological options. #CanNASH2021 @CCO_Hepatitis #NAFLD @CASLupdates @McGillGI
https://t.co/TJqBZo4gsE

My PhD student published a review article where we look at what awaits beyond sustained virological response in hepatitis C in terms of metabolic and cardiovascular complications. [DOI: 10.3748/wjg.v27.i17.1959] https://t.co/PrdW2g3mqp #HCV @FRQS1 @McGillGI @canhepc #CanNASH2021
![GiadaSebastiani's tweet photo. My PhD student published a review article where we look at what awaits beyond sustained virological response in hepatitis C in terms of metabolic and cardiovascular complications. [DOI: 10.3748/wjg.v27.i17.1959] https://t.co/PrdW2g3mqp #HCV @FRQS1 @McGillGI @canhepc #CanNASH2021 https://t.co/cIgBGlO4UQ](https://pbs.twimg.com/media/E1BOgiTXIAA-ewT.jpg)
Join me at @CanLiverMeeting, where I present a poster on #NAFLD knowledge in Canada! 53% of PCPs, 20% of specialists, and 35% of nurses think NAFLD prevalence is < 15%. Full paper just published in Canadian Liver Journal! #CLM21 #CanNASH2021 @utpjournals https://t.co/LsjeIFNRIp

Join me today May 3 at 1.30 pm at the Canadian Liver Meeting for a comprehensive lecture on #NAFLD. We will go together through epidemiology, pathogenesis, diagnosis and treatment of this frequent and deadly disease! @LiverNurseCA @CASLupdates @CanLiverMeeting #CLM21 #CanNASH2021

I'm presenting next week at @CanLiverMeeting on the impact of obesity on non-invasive tests for liver fibrosis in people with HIV, who are at high risk for #NAFLD. #CanNASH2021 #HIV
Presenting in an e-poster during poster tour 3 (May 4):
https://t.co/2BeOWBt3I9

My research program on #NAFLD has been funded by Fonds de Recherche Sante Quebec!! I am recipient of a 4 years salary award, which will be instrumental to continue my projects on this silent killer.@McGillGI @FRQS1 #communauteFRQ #CANNash2021
https://t.co/uAjoGDPTK1
So exciting!! Our collaborative paper on liver-related events and survival in NAFLD represents the cover page of Clinical Gastroenterology Hepatology, April issue!! doi: 10.1016/j.cgh.2020.06.045. #NAFLD @AGA_CGH @McGillGI #CanNASH2021 @CASLupdates

Excellent positions paper produced by the European Association for the Study of the Liver on the use of COVID-19 vaccines in patients with liver disease. SARS-CoV-2 vaccination recommended in patients with chronic liver disease. #CanNASH2021 @EASLnews
https://t.co/C1nzntx24F...

Mediterranean diet, a great ally against fatty liver!! A publication in @Gut_BMJ shows that, compared to healthy dietary guidelines, green Mediterranean diet (enriched in polyphenols) decreases weight and intrahepatic fat in obese patients!! #mediterraneandiet #NAFLD #CanNASH2021

Stay tuned. CanNASH will be launching a new website and social media channel! We want to stay connected with you to continue the #NASH conversation, enhance awareness, support unmet medical needs and create a call-to-action. #CanNASH2021 #NAFLD @CanLiverMeeting @LiverNurseCA
Thank you for attending the First CanNASH International Workshop on NASH. Please share your biggest insights, key takeaways and additional educational needs using #CanNASH2021. #NASH @CASLupdates @CanLiverMeeting @LiverNurseCA @CdnLiverFdtn
We are thrilled to be supporting and attending the 1st International Workshop CanNASH Joint with the Single Topic Conference CASL 2021! Excellent speakers and insight about NAFLD & NASH. #CanNASH2021 #STC21
Did you catch the fantastic sessions today at the CASL #canNASH2021 #STC21? It's not too late to register and attend tomorrow's stellar virtual program >> visit https://t.co/Vm573Cjgu4 and sign up now!

Liver biopsies remain important but have challenges especially in clinical trials especially given the intra-observer variability. #CanNASH2021.

Master class on liver biopsy NAFLD pathology by Dr. Brunt. Important highlight is the progression and regression of fibrosis #CanNASH2021

Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.5M followers

Barack Obama 
@barackobama
118.7M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
83.9M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.3M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.1M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers










